Darko Orešković, Anđelo Kaštelančić, Marina Raguž, Fadi Almahariq, Dominik Romić, Domagoj Dlaka, Andrea Janeš, Vivian Milotić, Sabina Novaković, Darko Chudy
Venous thromboembolism (VTE) is a significant public health issue causing severe morbidity and mortality. One of the most vulnerable populations for VTE development are cancer patients. And among them, patients with brain tumors have arguably the highest risk of developing this often fatal complication. Hyperglycemia is a well-known factor which leads to a wide variety of pro-thrombotic changes. In this article, we review the current literature on the topic of VTE in brain tumor patients. We also discuss the known correlation between VTE and glycemia, as well as the importance and frequency of glycemia dysregulation in brain tumor patients...
October 25, 2021: Medical Hypotheses